Female Sexual Dysfunction Clinical Trial
Official title:
Phase 2 Clinical Study to Evaluate the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Gel Form Applied to Women With Sexual Arousal Disorder
To determine the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder.
FSAD is defined as the recurrent inability to attain or maintain sufficient genital arousal during sexual activity. Therefore, a healthy blood flow is central to the physiological processes related to sexual arousal, leading to genital lubrication, warmth, and clitoral protrusion. The vasculature and blood flow in vaginal tissue can be compromised due to natural aging and various risk factors, including cigarette smoking, alcohol abuse, lack of exercise, high-fat diets, hypertension, hypercholesterolemia, and diabetes mellitus. All these risk factors and conditions are highly prevalent among women and can lead to FSAD. BZ371A offers a potential solution by increasing blood flow in genital tissue through its unique mechanism of action, thereby restoring vascular homeostasis and the physiological processes related to sexual arousal in women. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05806424 -
Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
|
||
| Completed |
NCT01364623 -
PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women
|
Phase 1 | |
| Completed |
NCT06060691 -
the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction
|
Phase 1 | |
| Recruiting |
NCT04419961 -
Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester
|
N/A | |
| Completed |
NCT04122703 -
Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction
|
N/A | |
| Recruiting |
NCT03498443 -
Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
|
||
| Completed |
NCT03232801 -
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
|
N/A | |
| Completed |
NCT04124640 -
Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
|
||
| Completed |
NCT00995072 -
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
|
N/A | |
| Active, not recruiting |
NCT05168371 -
Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction
|
N/A | |
| Completed |
NCT04384172 -
Effect of Peripheral Neuromodulation on Vaginal Blood Flow
|
N/A | |
| Recruiting |
NCT06237166 -
Evaluation of an Online Intervention for Female Sexual Dysfunction
|
N/A | |
| Completed |
NCT03463707 -
BP101 for Adults With Female Sexual Dysfunction
|
Phase 3 | |
| Recruiting |
NCT01078077 -
The Impact of a Topical Vasodilating Cream on Female Sexual Experience
|
N/A | |
| Completed |
NCT01724658 -
Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women
|
Phase 2 | |
| Completed |
NCT02229721 -
Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women
|
Phase 2 | |
| Completed |
NCT00479570 -
Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.
|
Phase 2 | |
| Withdrawn |
NCT02862184 -
Female Sexual Dysfunction, Risks and Outcomes (FSFI)
|
N/A | |
| Completed |
NCT01195701 -
Clitoral Location in Relation to Sexual Function Using Pelvic Imaging
|
N/A | |
| Completed |
NCT04484753 -
Validation of iPelvis App for Female Pelvic Floor Dysfunction
|
N/A |